What Is the Benefit of Tranexamic Acid vs Reinfusion Drains in Total Joint Arthroplasty?

Journal of Arthroplasty

Volumn 31, Issue 1, 2016, Pages 76-80

  Springer, Bryan D ^a   Odum, Susan M ^a   Fehring, Thomas K ^a  

^a ORTHOCAROLINA HIP AND KNEE CENTER   (United States)

Author keywords

Allogenic blood; Blood loss; Randomized clinical trial; Total joint arthroplasty; Transexamic acid

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; ERYTHROPOIETIN; IRON;

ADULT; AGED; ALLOTRANSPLANTATION; ARTHROPLASTY; ARTICLE; AUTOTRANSFUSION UNIT; BLOOD TRANSFUSION; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; COST CONTROL; DRUG EFFICACY; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TOTAL HIP PROSTHESIS; TOTAL JOINT ARTHROPLASTY; TOTAL KNEE REPLACEMENT; BLOOD AUTOTRANSFUSION; DRAINAGE; HIP REPLACEMENT; KNEE REPLACEMENT; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION, AUTOLOGOUS; DRAINAGE; ERYTHROPOIETIN; FEMALE; HEALTH CARE COSTS; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84953836254     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2015.08.006     Document Type: Article

References (34)

1. Kamath A.F., Pagnano M.W. Blood management for patients undergoing total joint arthroplasty. J Bone Joint Surg Rev 2013, 1(2):e1.
2. Saleh A., Small T., Chandran Pillai A.L., et al. Allogenic blood transfusion following total hip arthroplasty: results from the Nationwide Inpatient Sample, 2000 to 2009. J Bone Joint Surg Am 2014, 96(18):e155.
3. Slappendel R. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2005, 20(3):407. [author reply 407].
4. Bong M.R., Patel V., Chang E., et al. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty 2004, 19(3):281.
5. Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010, 113(2):482.
6. Levine B.R., Haughom B., Strong B., et al. Blood management strategies for total knee arthroplasty. J Am Acad Orthop Surg 2014, 22(6):361.
7. Sculco T.P., Baldini A., Keating E.M. Blood management in total joint arthroplasty. Instr Course Lect 2005, 54:51.
8. Woolson S.T., Wall W.W. Autologous blood transfusion after total knee arthroplasty: a randomized, prospective study comparing predonated and postoperative salvage blood. J Arthroplasty 2003, 18(3):243.
9. Sukeik M., Alshryda S., Haddad F.S., et al. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg (Br) 2011, 93(1):39.
10. Kagoma Y.K., Crowther M.A., Douketis J., et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009, 123(5):687.
11. Keating E.M., Meding J.B. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg 2002, 10(6):393.
12. Horstmann W.G., Swierstra M.J., Ohanis D., et al. Reduction of blood loss with the use of a new combined intra-operative and post-operative autologous blood transfusion system compared with no drainage in primary total hip replacement. Bone Joint J 2013, 95-B(5):616.
13. Cip J., Widemschek M., Benesch T., et al. Does single use of an autologous transfusion system in TKA reduce the need for allogenic blood? A prospective randomized trial. Clin Orthop Relat Res 2013, 471(4):1319.
14. Thomassen B., den Hollander P., Kaptijn H., et al. Autologous wound drains have no effect on allogeneic blood transfusions in primary total hip and knee replacement a three-arm randomised trial. Bone Joint J 2014, 96(6):765.
15. Al-Zahid S., Davies A.P. Closed suction drains, reinfusion drains or no drains in primary total knee replacement?. Ann R Coll Surg Engl 2012, 94(5):347.
16. Martin A., von Strempel A. Transfusion of autologous blood from reinfusion systems in total knee arthroplasty. Int Orthop 2006, 30(6):541.
17. Moonen A.F., Knoors N.T., van Os J.J., et al. Retransfusion of filtered shed blood in primary total hip and knee arthroplasty: a prospective randomized clinical trial. Transfusion 2007, 47(3):379.
18. Haien Z., Yong J., Baoan M., et al. Post-operative auto-transfusion in total hip or knee arthroplasty: a meta-analysis of randomized controlled trials. PLoS One 2013, 8(1):e55073.
19. Wong B.I., McLean R.F., Fremes S.E., et al. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg 2000, 69(3):808.
20. Charoencholvanich K., Siriwattanasakul P. Tranexamic acid reduces blood loss and blood transfusion after TKA: a prospective randomized controlled trial. Clin Orthop Relat Res 2011, 469(10):2874.
21. Hiippala S.T., Strid L.J., Wennerstrand M.I., et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997, 84(4):839.
22. Yue C., Kang P., Yang P., et al. Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty 2014, 29(12):2452.
23. Wind T.C., Barfield W.R., Moskal J.T. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty. J Arthroplasty 2014, 29(2):387.
24. Yang Z.G., Chen W.P., Wu L.D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012, 94(13):1153.
25. Oremus K., Sostaric S., Trkulja V., et al. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion 2014, 54(1):31.
26. Álvarez J.C., Santiveri F.X., Ramos I., et al. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion 2008, 48(3):519.
27. Hourlier H., Fennema P. Chemoprophylaxis without intra-articular wound drainage can replace autotransfusion in primary TKA. Orthopedics 2011, 34(6):433.
28. Shander A., Hofmann A., Ozawa S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010, 50(4):753.
29. Cheng S.C., Hung T.S., Tse P.Y. Investigation of the use of drained blood reinfusion after total knee arthroplasty: a prospective randomised controlled study. J Orthop Surg (Hong Kong) 2005, 13(2):120.
30. Munoz M., Ariza D., Campos A., et al. The cost of post-operative shed blood salvage after total knee arthroplasty: an analysis of 1,093 consecutive procedures. Blood Transfus 2013, 11(2):260.
31. Newman J.H., Bowers M., Murphy J. The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. J Bone Joint Surg (Br) 1997, 79(4):630.
32. Tuttle J.R., Ritterman S.A., Cassidy D.B., et al. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014, 29(8):1512.
33. Chimento G.F., Huff T., Ochsner J.L., et al. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013, 28(8 Suppl.):74.
34. Gillette B.P., Maradit Kremers H., Duncan C.M., et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013, 28(8 Suppl.):137.